Join
Live feed
·
PRReleasevia Quantisnow
Quanterix Corporation logo
Tempus AI Inc. logo

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

ByQuantisnow·Wall Street's wire, on your screen.
QTRX· Quanterix CorporationTEM· Tempus AI Inc.
IndustrialsTechnology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QTRX (Quanterix Corporation), TEM (Tempus AI Inc.) and more on Quantisnow.